Then, we analyzed the CMs of PA treated hepatoma cells for angiogenic factors, potentially regulating RUNX1 expression, such as VEGF, PDGF-BB and TGF-β, well known for their proangiogenic and fibrogenic role [16]. The gene discussed is RUNX1; the disease is hepatocellular carcinoma.